Project Number 1R01AG076634-01 Agency/Funding Organization NIA Funding Year 2022 View Full Project Details for Phase II randomized controlled trial of benfotiamine in early Alzheimer's Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) j. Metabolism and Bioenergetics Researcher and Organization Principal Investigator GIBSON, GARY E Principal Investigator First Name GARY E Principal Investigator Last Name GIBSON Awardee Organization WINIFRED MASTERSON BURKE MED RES INST Awardee State New York, N.Y. Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-18-878: Late Stage Clinical Trials for the Spectrum of Alzheimers Disease and Age-related Cognitive Decline (R01 Clinical Trial Required) FY Overall Cost $9,664,204 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official RYAN, LAURIE M
